Flowchart of overall study protocol. by Yongwoo Lee (2265172)

Subjects:

Changes in symptom scores and signs of dry eye disease and meibomian gland dysfunction after treatment with intensive pulse light and meibomian gland expression (n =  218). by Yongwoo Lee (2265172)

Subjects:

Change in the vertical distribution of the lipid layer thickness after intensive pulse light treatment (IPL; nm) combined with meibomian gland expression (MGX). by Yongwoo Lee (2265172)

Subjects:

Patient demographics. by Yongwoo Lee (2265172)

Subjects:

Representative liver histology of normal control (A), low-dose Olanzapine (B), negative control (C), test (D), and positive control (E) groups (Hematoxylin and Eosin stain, ×400 ma... by Elsie D. Oduor (22521785)

Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

Subjects:

Odds ratio (OR) for depression (HADS-D>=8) with 95% confidence interval (CI). Analyses are run using the weighted survey design on the sub-sample with non-missing for all included... by Maria Lage Barca (4515385)

Subjects:

Potential reduction in number (and %) with depression in the Norwegian 70 + population for year 2023 in the scenarios where loneliness is reduced by 10%, 20%, 30%, 40%, 50%, and 10... by Maria Lage Barca (4515385)

Subjects:

Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

Subjects:

Standardized prevalence* HADS-D>=8 with 95% CI by sex, time, age group, and living situation. by Maria Lage Barca (4515385)

Subjects:

Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

Subjects:

Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

Subjects:

Standardized** prevalence of depression (HADS-D>=8) with 95% CI by sex and year, age 70 + . by Maria Lage Barca (4515385)

Subjects:

Standardized prevalence of depression (HADS-D>=8 with 95% CI) by sex, time, and age group. by Maria Lage Barca (4515385)

Subjects:

Standardized prevalence* of depression (HADS-D>=8) with 95% CI by sex, age, and self-reported loneliness. by Maria Lage Barca (4515385)

Subjects:

Projections of total number of 70 + yr olds with depression (HADS-D>=8) in Norway for years 2025, 2030, 2035, 2040, 2045, 2050, and 2100. by Maria Lage Barca (4515385)

Subjects:

Sample characteristics among older adults with and without depression (HADS-D>=8) in HUNT2-4. N = 26,512. The HUNT Study, Norway. by Maria Lage Barca (4515385)

Subjects:

Smart spot and smart triage platform. by Rebecca Goertzen (22008461)

“…The inpatient mortality rate decreased from 5.1% in August 2018 to 2.6% in October 2023, with a significant increase in the number of cases with comparable illness severity.…”

HICH patient demographics during QI intervention. by Rebecca Goertzen (22008461)

“…The inpatient mortality rate decreased from 5.1% in August 2018 to 2.6% in October 2023, with a significant increase in the number of cases with comparable illness severity.…”

Total organic carbon and phenolic content of raw materials and fruit body cultivated (see S2 in S2 File for reference). by Caglar Akcay (6910697)

Subjects: